odevixibat

CHEBI:CHEBI_747934

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2564005
generic_name
odevixibat
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
ORAL
dosage_form
CAPSULE, COATED PELLETS
active_ingredient_strength
1200 ug/1
marketing_start_date
20210720
package_marketing_start_date
20-JUL-21
labeler_name
Albireo Pharma, Inc.
manufacturer_name
Albireo Pharma, Inc.
brand_name
BYLVAY
brand_name_base
BYLVAY
product_ndc
15054-3302
application_number
NDA215498
spl_id
556071dc-02b2-4d9b-9ed3-44343e0f2432
active_ingredient_name
ODEVIXIBAT
package_ndc
15054-3302-1
package_description
1 BOTTLE in 1 CARTON (15054-3302-1) / 30 CAPSULE in 1 BOTTLE
unii
2W150K0UUC
spl_set_id
151f1d3e-2bf4-47ce-b1be-a892de3258fa
nui
N0000193958
pharm_class_epc
Ileal Bile Acid Transporter Inhibitor [EPC]
pharm_class
Ileal Bile Acid Transporter Inhibitors [MoA]
pharm_class_moa
Ileal Bile Acid Transporter Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class